Getinge Neurally Adjusted Ventilatory Assist (NAVA)

Click2Contact

Respiratory failure is one main reason for admission to the neonatal and paediatric intensive care units.¹ Getinge’s Neurally Adjusted Ventilatory Assist (NAVA) was developed to use the patient’s own neural respiratory drive to control the ventilator.

Mechanical ventilation related complications occur in 40% of patients.^2,3 Non-invasive ventilation (NIV) aims to minimise negative consequences of invasive mechanical ventilation, such as ventilator associated pneumonia (VAP) and ventilator-induced lung injury (VILI) while supporting the patient’s breathing^4,5, and it is preferable as primary therapy.

NAVA and NIV-NAVA allow the neonates to regulate their own ventilation. Using neural trigger, the patient controls initiation and termination of breath, size of the breath, inspiratory time, respiratory rate and peak pressure, not the ventilator.

Studies show that neonates on NAVA and NIV-NAVA tend to have improved synchrony^6,7, reduced WOB^8,9 and protective tidal volumes and inspiratory pressures^7,10,11. They also show better gas exchange^12,13, less sedation^13,14, reduced apnoeas¹⁵ and improved comfort^14,16.

Click here for reference list.

For more information, visit https://www.getinge.com/anz/products/nava/.